Prescription drug · NDA
Yuvezzi NDC 84892-275
carbachol and brimonidine tartrate · Carbachol 27.5 mg/mL; Brimonidine tartrate 1 mg/mL · Solution/ drops · Ophthalmic · Visus Therapeutics, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84892-275-30 | 84892027530 | 6 POUCH in 1 CARTON (84892-275-30) / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02) / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01)Marketed from Feb 18, 2026 | |
| 84892-275-99 | 84892027599 | 1 POUCH in 1 CARTON (84892-275-99) / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02) / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01)Marketed from Feb 18, 2026 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Yuvezzi
- Generic name (nonproprietary)
- carbachol and brimonidine tartrate
- Active ingredients
- Carbachol — 27.5 mg/mLBrimonidine tartrate — 1 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Visus Therapeutics, Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 220142
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Agonists (Mechanism)Cholinergic Agonists (Mechanism)
- Identifiers
- Product ID 84892-275_52d67ffa-087d-08a9-e063-6294a90a6e39SPL ID 52d67ffa-087d-08a9-e063-6294a90a6e39SPL set ID 68198098-0f33-458f-83b8-eb2a5ec69012RxCUI 2736933, 2736939UNII 8Y164V895Y, 4S9CL2DY2HUPC 0384892275303
- Pharmacologic class
- Cholinergic Receptor Agonist; alpha-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484892027530followed by a unit qualifier and the quantityPackage 84892-0275-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
YUVEZZI™ is indicated for the treatment of presbyopia in adults. YUVEZZI is a combination of carbachol, a cholinergic agonist, and brimonidine, an alpha-adrenergic receptor agonist, indicated for the treatment of presbyopia in adults. ( 1 )
Excerpt only. Read the full label for complete information.